2001
DOI: 10.1001/jama.286.24.3083
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis

Abstract: Our results support a role of EBV in the etiology of MS.

Search citation statements

Order By: Relevance

Paper Sections

Select...
422
96
67
12

Citation Types

21
422
4
14

Year Published

1988
1988
2026
2026

Publication Types

Select...
451
63
29
12

Relationship

19
536

Authors

Journals

citations

Cited by 555 publications

(461 citation statements)
references

References 45 publications

21
422
4
14
Order By: Relevance
How this paper cites the one you are viewing
“…This could explain the higher prevalence observed in our study, although it is possible that this could reflect a true difference in prevalence. Even though we found that anti-VCA seropositivity was significantly associated with having MS, the antibody titer was not significantly different between cases and controls, unlike what was previously reported [42,43]. On the other hand, the mean anti-EBNA-1 antibody titer was significantly higher in MS cases compared to controls.…”
Section: Discussion
contrasting
confidence: 99%
How this paper cites the one you are viewing
“…This could explain the higher prevalence observed in our study, although it is possible that this could reflect a true difference in prevalence. Even though we found that anti-VCA seropositivity was significantly associated with having MS, the antibody titer was not significantly different between cases and controls, unlike what was previously reported [42,43]. On the other hand, the mean anti-EBNA-1 antibody titer was significantly higher in MS cases compared to controls.…”
Section: Discussion
contrasting
confidence: 99%
How this paper cites the one you are viewing
“…This is interesting, as anti‐EBV‐EA‐R IgG is canonically only detectable for up to 2 months after primary infection or reactivation , although there have been longitudinal studies, one in healthy adults following infectious mononucleosis and one in persons with MS , where low/moderate levels of anti‐EBV‐EA‐R IgG were detected over 6–12 months of follow‐up. Our finding of prevalent sustained anti‐EBV‐EA‐R IgG levels is atypical in comparison with the MS literature, with others finding samples with detectable anti‐EBV‐EA IgG in just over half of participants or none at all . The question is whether these sustained anti‐EBV‐EA‐R IgG levels should be interpreted as sustained lytic activity.…”
Section: Discussion
contrasting
confidence: 95%
How this paper cites the one you are viewing
“…This is in line with a prior report in adults26 but in contrast with two others in children 4, 27. Two small groups of controls were used in our former study which could explain differences in the findings 4.…”
Section: Discussion
supporting
confidence: 93%